Activated partial thromboplastin time (aPTT) =< . x ULN
Activated partial thromboplastin time (aPTT) =< . x ULN
Activated partial thromboplastin time (aPTT) =< . X ULN
Activated partial thromboplastin time (aPTT) =< . x institutional ULN (for participants on anticoagulation therapy, =< . x their baseline value)
Activated partial thromboplastin time (aPTT) =< . x institutional ULN (for participants on anticoagulation therapy, =< . x their baseline value)
INCLUSION - PROCUREMENT: If pheresis required to collect blood\r\n* Prothrombin time (PT) and activated partial thromboplastin time (APTT) <.  upper limit normal
Activated partial thromboplastin time (aPTT) within normal limits
PTT or activated partial thromboplastin time (aPTT) ? seconds above institutional ULN
Prothrombin Time (PT) and activated partial thromboplastin time (aPTT) <= .x the upper limit of normal.
Within  days of enrollment and with  h of starting lymphodepleting chemotherapy: Prothrombin time (PT) & activated partial thromboplastin time (aPTT) =< . X ULN (correction with vitamin K allowed) unless subject is\r\nreceiving anticoagulant therapy (which should be managed according to institutional norms prior to and after excisional biopsy).
Activated partial thromboplastin time (aPTT) ?.  ULN (Grade ?).
Activated partial thromboplastin time (aPTT), prothrombin time (PT) =< . x upper limit of normal (ULN)
Activated partial thromboplastin time (aPTT) > . seconds
Activated partial thromboplastin time (aPTT) =< . X ULN
aPTT (activated partial thromboplastin time) =< . x ULN\r\n* NOTE: if patient is not on anticoagulant therapy (a therapeutic PT and/or INR and aPTT is acceptable if the patient is on anticoagulants)
A prothrombin time (PT) or activated partial thromboplastin time (aPTT) above the ULN or a history of a coagulopathy or bleeding disorder.
Activated partial thromboplastin time (aPTT) within . x ULN institutional limits, except where a lupus anti-coagulant has been confirmed
Prothrombin time (PT)/activated partial thromboplastin time (aPTT) within normal limits at time of surgery
Total bilirubin =< . X institutional limits; subjects with Gilbert's syndrome may have a bilirubin > . x upper limit of normal (ULN); activated partial thromboplastin time (aPTT), prothrombin time (PT) not to exceed . x ULN
Activated partial thromboplastin time (aPTT) < . x ULN
Normal coagulation parameters (prothrombin time [PT], activated partial thromboplastin time [aPTT])
Activated partial thromboplastin time (aPTT) =< . x ULN for the laboratory
Activated partial thromboplastin time (aPTT) =< . x IULN
Activated partial thromboplastin time (aPTT) =< . x ULN unless the patient is receiving anticoagulant therapy
Activated partial thromboplastin time (aPTT) =< . x ULN
Abnormal coagulation parameter (prothrombin time [PT] or activated partial thromboplastin time [aPTT] > .x longer than standard reference)
Normal prothrombin time (PT/INR) and activated partial thromboplastin time (aPTT)
Activated partial thromboplastin time (aPTT) =< . x ULN or within therapeutic range if receiving anticoagulant therapy OR
Activated partial thromboplastin time (APTT)/PTT =< . x institutional ULN
Activated partial thromboplastin time (aPTT) =< . x ULN for the laboratory
ARM A: obtained =<  days prior to registration: \r\n* Activated partial thromboplastin time (aPTT) =< . x ULN
Activated partial thromboplastin time (aPTT), prothrombin time (PT) =< . x upper limit of normal (ULN)
Obtained within  days prior to registration: Activated partial thromboplastin time (aPTT) =<  x ULN (Note: use of vitamin K antagonist is not allowed)
Prothrombin time (PT) and activated partial thromboplastin time (aPTT) =< upper limit of normal (ULN) for age
Prothrombin time (PT) and activated partial thromboplastin time (aPTT) =< . x ULN
Prothrombin time (PT) and activated partial thromboplastin time (aPTT) =< . x upper limit of normal (ULN)
Activated partial thromboplastin time (aPTT) =< . x ULN
Prothrombin time (PT) and activated partial thromboplastin time (APTT) =< . times upper limit of normal
Prothrombin time (PT) or prolongation of the activated thromboplastin time (aPTT) >. ULN or active uncontrolled coagulopathy or bleeding disorder.
Activated Partial Thromboplastin Time (aPTT) ?. X ULN
Prothrombin time (PT) and activated partial thromboplastin time (aPTT) =< . x ULN for the lab
Activated partial thromboplastin time (aPTT) =< . x ULN (tested within  days prior to registration)
Coagulopathy (as evidence by prothrombin time [PT] or activated partial thromboplastin time [APTT] > . times upper limit of normal in patients not undergoing anticoagulation)
Activated partial thromboplastin time (aPTT) =< . x ULN
Absence of active treatment with systemic anticoagulation and a baseline prothrombin time (PT) and activated partial thromboplastin time (aPTT) that does not exceed . x ULN
Activated partial thromboplastin time (aPTT) =< . x IULN
Prothrombin time (PT)/activated partial thromboplastin time (aPTT) =< . x institutions ULN
Activated partial thromboplastin time (aPTT) > . x ULN (patients on heparin treatment must have an aPTT between . - . x ULN), or
Activated partial thromboplastin time (aPTT) =< . x institutional upper limits of normal
Activated partial thromboplastin time (aPTT) =< . X ULN; subjects receiving anticoagulant therapy are eligible if their aPTT is stable and within the recommended range for the desired level of anticoagulation
Activated partial thromboplastin time (aPTT) =< . X ULN
Activated prothrombin time (APTT) =< . x ULN
Activated partial thromboplastin time (aPTT) =< . X ULN
Activated partial thromboplastin time (aPTT) =< . X ULN
For patients undergoing biopsy procedures: Prothrombin time (PT) and activated partial thromboplastin time (aPTT) must be within the normal range
Activated partial thromboplastin time (aPTT) =< . x ULN
Prothrombin time (PT) and activated partial thromboplastin time (aPTT) <. times the upper limit of normal (ULN)
Prothrombin time and activated partial thromboplastin time (aPTT) < . times the upper limit of normal (ULN)
Coagulopathy (as evidenced by prothrombin time [PT] or activated partial thromboplastin time [APTT] > . times in control patients not undergoing anticoagulation)
Activated partial thromboplastin time (aPTT) ? . x the upper limit of the normal range (ULN) per institutional laboratory normal range
Activated partial thromboplastin time (aPTT) ? . x the upper limit of the normal range (ULN) per institutional laboratory normal range
Activated partial thromboplastin time (APTT) =< . x upper limit of normal unless patient is receiving anticoagulants; if patient is on anticoagulation therapy, levels should be within therapeutic range
aPTT ? . x ULN
Patients with known bleeding diathesis, or PT (Prothrombin time) or aPTT (activated partial thromboplastin time) > .x ULN or <.x LLN.
Prothrombin time (PT) and activated partial thromboplastin time (aPTT) <=.*ULN
Activated partial thromboplastin time =< . times ULN
Activated partial thromboplastin time =< . times ULN
Activated partial thromboplastin time (aPTT) ? .  ULN
Abnormal coagulation (partial thromboplastin [PT] or activated partial thromboplastin time [aPTT] > % above normal limits)
Within  days of surgery: Activated partial thromboplastin time (aPTT) =< 
Prothrombin time (PT)/activated partial thromboplastin time (aPTT) =< . x institutional upper limit of normal (ULN) for age
Activated partial thromboplastin time (aPTT) =<  (within  days of surgery)
Activated partial thromboplastin time (aPTT) within normal institutional limits
Activated partial thromboplastin time (aPTT) and prothrombin time (PT) not to exceed . x upper limit of normal (ULN), completed within  weeks prior to start of protocol therapy
Activated partial thromboplastin time (aPTT) or plasma thromboplastin (PT) outside the institution's standard of care.